InvestorsHub Logo
Followers 2
Posts 436
Boards Moderated 0
Alias Born 01/14/2014

Re: None

Thursday, 05/03/2018 3:32:32 AM

Thursday, May 03, 2018 3:32:32 AM

Post# of 807
624 - The Use of Automation in the Development of Lentiviral Vector Producer Cell Lines

In conclusion, the isolation and screening of larger numbers of clones (>1000) using the ACSS leads to the selection of higher titre LV producing clones than previously achieved when screening smaller numbers of clones (100-200) manually. OXB now has capability of leveraging this technology in generating cell lines based on tet-repressor and/or TRiP system for serum-free, suspension production of viral vectors.


HTTPS://plan.core-apps.com/asgct2018/abstract/cbbcf41d-afe9-4b9a-a37e-2327363445f1